176 related articles for article (PubMed ID: 25685387)
1. Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes.
Lai S; Brookes C; Prosser DO; Lan CC; Doherty E; Love DR
Sultan Qaboos Univ Med J; 2015 Feb; 15(1):e58-70. PubMed ID: 25685387
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients.
Alvarez C; Ortega-Hernández V; Cortez A; Carvallo P
Mol Biol Rep; 2022 Aug; 49(8):7531-7539. PubMed ID: 35596815
[TBL] [Abstract][Full Text] [Related]
4. Laboratory Verification of a
Poon KS; Chiu L; Tan KM
Glob Med Genet; 2021 Jun; 8(2):62-68. PubMed ID: 33987625
[No Abstract] [Full Text] [Related]
5. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
6. Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing.
Ruiz A; Llort G; Yagüe C; Baena N; Viñas M; Torra M; Brunet A; Seguí MA; Saigí E; Guitart M
Biomed Res Int; 2014; 2014():542541. PubMed ID: 25136594
[TBL] [Abstract][Full Text] [Related]
7. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
[TBL] [Abstract][Full Text] [Related]
8. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing.
Dacheva D; Dodova R; Popov I; Goranova T; Mitkova A; Mitev V; Kaneva R
Mol Diagn Ther; 2015 Apr; 19(2):119-30. PubMed ID: 25893891
[TBL] [Abstract][Full Text] [Related]
9. Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
McVeigh TP; Cody N; Carroll C; Duff M; Farrell M; Bradley L; Gallagher D; McDevitt T; Green AJ
Cancer Genet; 2017 Aug; 214-215():1-8. PubMed ID: 28595730
[TBL] [Abstract][Full Text] [Related]
10. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
[TBL] [Abstract][Full Text] [Related]
11. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
12. Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.
Costa JL; Sousa S; Justino A; Kay T; Fernandes S; Cirnes L; Schmitt F; Machado JC
Hum Mutat; 2013 Apr; 34(4):629-35. PubMed ID: 23315985
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.
Takano EA; Mitchell G; Fox SB; Dobrovic A
BMC Cancer; 2008 Feb; 8():59. PubMed ID: 18298804
[TBL] [Abstract][Full Text] [Related]
14. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing.
Hirotsu Y; Nakagomi H; Sakamoto I; Amemiya K; Mochizuki H; Omata M
Mol Genet Genomic Med; 2015 Mar; 3(2):121-9. PubMed ID: 25802882
[TBL] [Abstract][Full Text] [Related]
15. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.
D'Argenio V; Esposito MV; Telese A; Precone V; Starnone F; Nunziato M; Cantiello P; Iorio M; Evangelista E; D'Aiuto M; Calabrese A; Frisso G; D'Aiuto G; Salvatore F
Clin Chim Acta; 2015 Jun; 446():221-5. PubMed ID: 25896959
[TBL] [Abstract][Full Text] [Related]
16. Massive Parallel Sequencing for Diagnostic Genetic Testing of BRCA Genes--a Single Center Experience.
Ermolenko NA; Boyarskikh UA; Kechin AA; Mazitova AM; Khrapov EA; Petrova VD; Lazarev AF; Kushlinskii NE; Filipenko ML
Asian Pac J Cancer Prev; 2015; 16(17):7935-41. PubMed ID: 26625824
[TBL] [Abstract][Full Text] [Related]
17. A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing.
Ellison G; Huang S; Carr H; Wallace A; Ahdesmaki M; Bhaskar S; Mills J
BMC Clin Pathol; 2015; 15():5. PubMed ID: 25859162
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E
Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234
[TBL] [Abstract][Full Text] [Related]
19. Detection of false positive mutations in BRCA gene by next generation sequencing.
Suryavanshi M; Kumar D; Panigrahi MK; Chowdhary M; Mehta A
Fam Cancer; 2017 Jul; 16(3):311-317. PubMed ID: 27848044
[TBL] [Abstract][Full Text] [Related]
20. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
